Intrinsiqq
Irhythm Technologies Inc. logo

Irhythm Technologies Inc. Insider Trading

IRTC

⊜ Compare
Last 12 months

Insiders bought 57K and sold $25.4M on the open market.

11% of the selling was scheduled in advance under 10b5-1 plans. President and CEO Quentin S. Blackford sold $3.46M on Feb 25, 12% of their stake, outside a plan.

Net open-market
−$25.4M
1 buy · 38 sales
Under a 10b5-1 plan
11%
of the value sold
Insiders who bought / sold
1 / 12
executives and directors
Last open-market buy
May 2026
May 11, 2026

Get an email when IRTC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 2No plan
    Daniel G. Wilson
    Chief Financial Officer · sold 773 at $121.83
    94K
    2.2% of stake
  • Aug 10No plan
    Minang Turakhia
    Chief Med/sci Ofcr EVP Advtech · sold 7,093 at $124.65
    884K
    11% of stake
  • Aug 10No plan
    Sumi Shrishrimal
    EVP, Chief Risk Officer · sold 5,372 at $124.65
    670K
    11% of stake
  • Aug 10No plan
    Chad Patterson
    Chief Comm & Product Officer · sold 7,093 at $124.65
    884K
    10% of stake
  • Aug 10No plan
    Patrick Michael Murphy
    CBO and CLO · sold 7,093 at $124.65
    884K
    9.2% of stake
  • Aug 10No plan
    Quentin S. Blackford
    President and CEO · sold 26,859 at $124.65
    $3.35M
    11% of stake
  • Aug 3No plan
    Julianne Rodda
    EVP, Chief People Officer · sold 2,112 at $122.12
    258K
    10% of stake
  • Aug 3No plan
    Mervin Smith
    EVP Strategic Business Ops · sold 617 at $122.12
    75K
    2.7% of stake
  • Aug 3No plan
    Chad Patterson
    Chief Comm & Product Officer · sold 2,712 at $122.12
    331K
    4.6% of stake
  • Jul 2No plan
    Sean Clinton Freeman
    EVP, Strategy & Corp Devt · sold 918 at $124.71
    114K
    6.3% of stake
  • Jul 2No plan
    Minang Turakhia
    Chief Med/sci Ofcr EVP Advtech · sold 1,423 at $124.71
    177K
    2.6% of stake
  • Jun 2No plan
    Marc Wade Rosenbaum
    Chief Accounting Officer · sold 729 at $108.19
    79K
    4.3% of stake
  • Jun 2No plan
    Sumi Shrishrimal
    EVP, Chief Risk Officer · sold 1,716 at $108.19
    186K
    4.1% of stake
  • May 1110b5-1 plan
    Abhijit Y Talwalkar
    Director · sold 5,312 at avg $117.93
    626K
    21% of stake
  • May 11
    Abhijit Y Talwalkar
    Director · bought 5,312 at $10.71
    57K
    35% of stake
  • May 4No plan
    Brian Lee Lawrence
    Chief Technology Officer · sold 1,014 at $120.80
    122K
    4.8% of stake
  • Mar 1610b5-1 plan
    Mervin Smith
    EVP Strategic Business Ops · sold 2,585 at $114.30
    295K
    10% of stake
  • Mar 2No plan
    Mervin Smith
    EVP Strategic Business Ops · sold 1,352 at avg $128.44
    174K
    5.0% of stake
  • Mar 2No plan
    Minang Turakhia
    Chief Med/sci Ofcr EVP Advtech · sold 4,027 at avg $128.45
    517K
    6.8% of stake
  • Mar 2No plan
    Marc Wade Rosenbaum
    Chief Accounting Officer · sold 816 at avg $128.45
    105K
    4.7% of stake
  • Mar 2No plan
    Daniel G. Wilson
    Chief Financial Officer · sold 3,395 at avg $128.45
    436K
    8.7% of stake
  • Mar 2No plan
    Sumi Shrishrimal
    EVP, Chief Risk Officer · sold 2,830 at avg $128.44
    363K
    6.3% of stake
  • Mar 2No plan
    Chad Patterson
    Chief Comm & Product Officer · sold 4,444 at avg $128.44
    571K
    7.1% of stake
  • Mar 2No plan
    Patrick Michael Murphy
    CBO and CLO · sold 4,357 at avg $128.44
    560K
    6.4% of stake
  • Mar 2No plan
    Quentin S. Blackford
    President and CEO · sold 13,813 at avg $128.44
    $1.77M
    6.3% of stake
  • Feb 25No plan
    Mervin Smith
    EVP Strategic Business Ops · sold 4,041 at $135.42
    547K
    17% of stake
  • Feb 25No plan
    Minang Turakhia
    Chief Med/sci Ofcr EVP Advtech · sold 7,804 at $135.42
    $1.06M
    14% of stake
  • Feb 25No plan
    Marc Wade Rosenbaum
    Chief Accounting Officer · sold 4,797 at $135.42
    650K
    24% of stake
  • Feb 25No plan
    Daniel G. Wilson
    Chief Financial Officer · sold 5,188 at $135.42
    703K
    14% of stake
  • Feb 25No plan
    Sumi Shrishrimal
    EVP, Chief Risk Officer · sold 6,217 at $135.42
    842K
    14% of stake
  • Feb 25No plan
    Chad Patterson
    Chief Comm & Product Officer · sold 8,967 at $135.42
    $1.21M
    15% of stake
  • Feb 25No plan
    Patrick Michael Murphy
    CBO and CLO · sold 7,805 at $135.42
    $1.06M
    11% of stake
  • Feb 25No plan
    Quentin S. Blackford
    President and CEO · sold 25,540 at $135.42
    $3.46M
    12% of stake
  • Feb 2410b5-1 plan
    Mervin Smith
    EVP Strategic Business Ops · sold 732 at $140.91
    103K
    4.6% of stake
  • Feb 2410b5-1 plan
    Marc Wade Rosenbaum
    Chief Accounting Officer · sold 280 at $140.91
    39K
    2.6% of stake
  • Feb 2310b5-1 plan
    Abhijit Y Talwalkar
    Director · sold 5,312 at avg $145.71
    774K
    21% of stake
  • Dec 2, 202510b5-1 plan
    Chad Patterson
    Chief Comm & Product Officer · sold 280 at $184.83
    52K
    0.6% of stake
  • Dec 2, 2025No plan
    Patrick Michael Murphy
    CBO and CLO · sold 2,478 at $184.83
    458K
    4.4% of stake
  • Nov 10, 202510b5-1 plan
    Abhijit Y Talwalkar
    Director · sold 5,312 at avg $174.13
    925K
    21% of stake
  • Nov 3, 2025No plan
    Quentin S. Blackford
    President and CEO · sold 14,059 at $182.94
    $2.57M
    7.9% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch IRTC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with IRTC

CompareIntrinsic value
OFIXOrthofix Medical Inc.
$9.72+10.96%18
ATECAlphatec Holdings Inc.
$8.28+10.84%45
INSPInspire Medical Systems, Inc.
$66.61+7.61%81
NVCRNovoCure Ltd.
$14.61+8.79%24
TNDMTandem Diabetes Care Inc.
$19.05+7.93%26
GKOSGlaukos Corporation
$246.70+5.86%55
UFPTUFP Technologies Inc.
$329.82+17.66%40
EMBCEmbecta Corp.
$6.52+7.24%37

Held by ETFs

IRTC is in 62 US ETFs. The largest of them, with IRTC's weight in each:

Spot a number that looks wrong? Check it in IRTC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing IRTC

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.